title: A phase II study of raltitrexed ('Tomudex') in patients with hepatocellular carcinoma.
authors.affiliation: Institut Gustave Roussy, Villeiuif, France.
authors.forename: P
authors.initials: P
authors.lastname: Rougier
authors.forename: M
authors.initials: M
authors.lastname: Ducreux
authors.forename: D
authors.initials: D
authors.lastname: Kerr
authors.forename: B I
authors.initials: BI
authors.lastname: Carr
authors.forename: E
authors.initials: E
authors.lastname: François
authors.forename: A
authors.initials: A
authors.lastname: Adenis
authors.forename: L
authors.initials: L
authors.lastname: Seymour
mesh_terms: D000328:Adult; D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy*; D005260:Female; D005493:Folic Acid Antagonists / Q000627:therapeutic use*; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011799:Quinazolines / Q000627:therapeutic use*; D013876:Thiophenes / Q000627:therapeutic use*
chemical_list: D000964:Antimetabolites, Antineoplastic; D005493:Folic Acid Antagonists; D011799:Quinazolines; D013876:Thiophenes; C068874:raltitrexed